TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
about
Changes in miRNA in the lung and whole blood after whole thorax irradiation in rats.MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.Factors Promoting Development of Fibrosis in Crohn's Disease.miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signalingRole for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.Antilipotoxicity Activity of Osmanthus fragrans and Chrysanthemum morifolium Flower Extracts in Hepatocytes and Renal Glomerular Mesangial Cells.Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.MicroRNAs associated with the development of kidney diseases in humans and animals.High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.Human CD36 overexpression in renal tubules accelerates the progression of renal diseases in a mouse model of folic acid-induced acute kidney injury.Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic miceMicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection
P2860
Q36311716-7690D609-5C73-40C3-BE1B-8E997AD1C8A0Q38948245-7512F7DA-0707-4DB4-8A5E-F5666EC73D58Q39453646-2E721C83-EE07-4016-A096-5DDF3942C499Q41228775-81211933-D839-4FCA-B08D-2245EE7BB03AQ42378473-6F64400D-8233-4407-92D4-B209637B2AA0Q47238218-1AA7D831-F048-46EB-A7C1-60F37D33D6CEQ48189832-68C8AC50-28AE-47DA-97B2-1A55021DAE7FQ48297020-15A9C2B1-95E1-4444-9546-0C9C886063BDQ50057516-E8B7DC5C-64B4-4836-AC8B-F5DD4DC7C60EQ50352301-5507E391-DE6B-40F4-964D-B5D61FA32914Q53695024-284594AC-20E2-4439-A0BB-CDCA2CA06D6AQ55207759-375C373D-50AC-430A-B86E-648BE190C282Q55249146-1335E952-63B7-48F6-B57E-F87F20A1948CQ57170561-DBC12616-2808-4C2A-B189-71306AF660BDQ58787180-36F27D69-340F-4396-B330-8CBD3B2A97D1
P2860
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@ast
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@en
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@nl
type
label
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@ast
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@en
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@nl
prefLabel
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@ast
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@en
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@nl
P2093
P2860
P921
P3181
P356
P1476
TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation
@en
P2093
Agnieszka Loboda
Jozef Dulak
Mateusz Sobczak
P2860
P304
P3181
P356
10.1155/2016/8319283
P407
P577
2016-01-01T00:00:00Z
2016-08-17T00:00:00Z